To date, no studies have reported HTRA4 expression in primary tumour samples, although a previous review has suggested that HtrA4 may be dysregulated in some cancers such as glioblastoma, breast carcinoma, and primary prostate carcinoma [91]. Here, HTRA4 is linked to prostate carcinoma.